VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs UnitedHealth Group Incorporated
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisUnitedHealth Group Incorporated
UNH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into UnitedHealth Group Incorporated's moat claims, evidence, and risks.
View UNH analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 64 / 100 for UnitedHealth Group Incorporated).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); UnitedHealth Group Incorporated has 4 segments (74.9% in UnitedHealthcare).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Weak.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; UnitedHealth Group Incorporated has 5 across 2.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
UnitedHealth Group Incorporated
UnitedHealthcare
U.S. health benefits / managed care (commercial, Medicare Advantage, Medicaid managed care)
United States (primarily)
Employers, individuals, and government-sponsored programs
Health insurer / managed care organization
74.9%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
AstraZeneca PLC strengths
UnitedHealth Group Incorporated strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
UnitedHealth Group Incorporated segments
Full profile >UnitedHealthcare
Oligopoly
Optum Health
Competitive
Optum Insight
Competitive
Optum Rx
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.